Is Emory or Rutgers better for a career in pharmaceuticals?

For a student who wants to enter the pharmaceutical industry directly after a bachelor’s degree, Rutgers has the more targeted ecosystem. Its Ernest Mario School of Pharmacy, pharmaceutical science options, and New Jersey location create unusually direct access to drug companies, contract research organizations, manufacturing, regulatory work, and industry-connected internships. Rutgers is especially compelling for students drawn to drug development, formulation, quality, regulatory affairs, commercial roles, or pharmacy-related science.

New Jersey remains one of the country’s major pharmaceutical and life-sciences hubs, so Rutgers students can pursue semester-time internships and build local professional connections rather than relying only on summer opportunities. Its pharmacy-school presence also means undergraduates are surrounded by faculty and peers focused specifically on medications and the drug-development pipeline.

Emory fits a different pharmaceutical path well. It is an excellent choice for a student interested in biomedical research, clinical trials, epidemiology, health outcomes, global health, or eventually earning an MD, PhD, MPH, or other advanced degree. Emory’s connections to major health-care institutions, the CDC, and Atlanta’s growing life-sciences community can be particularly valuable for careers involving clinical research, pharmacovigilance, medical affairs, public health, or health-policy work.

In either case, your internship record and hands-on research will matter more to employers than the school name alone.